Sort
46,585 grants matching “heart failure”
Device for Treatment of Cardiac No-Option Patients
$1,432,551Mengjun Wang · 3dt Holdings, Llc · R44 · FY2018 · HL
Objective Physical Activity and Cardiovascular Health in Older Women: OPACH2
$1,431,380Andrea Z. Lacroix · University Of California, San Diego · R01 · FY2022 · HL
New insights into the molecular regulation of mechanotransduction
$1,431,000Lindsay Case · Massachusetts Institute Of Technology · DP2 · FY2022 · GM
Generation of functional organs via developmental chimerism
$1,430,642Sean M Wu · Massachusetts General Hospital · DP2 · FY2008 · OD
Cardiac Biomarkers in Pediatric Cardiomyopathy
$1,430,582Steven Edward Lipshultz · University Of Miami School Of Medicine · R01 · FY2012 · HL
Data Science Research
$1,430,169Santosh Kumar · University Of Memphis · U54 · FY2017 · EB
A Pilot Clinical Study in Acute STEMI
$1,430,128Weizhong Cai · Angion Biomedica Corporation · R44 · FY2010 · HL
SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)
$1,429,986Mathew S Maurer · Columbia University Health Sciences · R01 · FY2021 · HL
Data Science Research
$1,427,853James M. Rehg · University Of Memphis · U54 · FY2016 · EB
Young Adult and Midlife Transitions in Physical Activity and Sedentary Behavior with Heart Failure Risk and Progression: Coronary Artery Risk Development in Young Adults (CARDIA)
$1,427,337Kelley Pettee Gabriel · University Of Alabama At Birmingham · R01 · FY2021 · HL
Myocardial Ischemia and Transfusion (MINT) - CCC
$1,425,410Jeffrey Lee Carson · Rbhs-Robert Wood Johnson Medical School · U01 · FY2017 · HL
GENETIC APPROACHES TO EARLY CARDIAC DEVELOPMENT
$1,425,320Baylor College Of Medicine · P01 · FY2000 · HL
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
$1,424,930Christine M Albert · Brigham And Women'S Hospital · R01 · FY2009 · HL
SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)
$1,424,662Mathew S Maurer · Columbia University Health Sciences · R01 · FY2020 · HL
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
$1,424,426Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2019 · HL
Investigations of Methylmalonic Acidemia and Related Disorders
$1,424,207Charles P Venditti · National Human Genome Research Institute · ZIA · FY2017 · HG
Women's Health Initiative Sleep Hypoxia Effects on Resilience (WHISPER)
$1,422,383Laura D. Baker · Wake Forest University Health Sciences · R01 · FY2019 · HL
ARIC CLINICAL EXAMINATION CENTER
$1,422,322Gerardo Heiss · Univ Of North Carolina Chapel Hill · N01 · FY2016 · HL
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
$1,422,291Dalane W Kitzman · Wake Forest University Health Sciences · R01 · FY2016 · AG
Probing sex differences in myocardial fibrosis at multiple length scales using biomaterials
$1,422,000Brian Alberto Aguado · University Of California, San Diego · DP2 · FY2023 · HL
IGF::OT::IGF - R&D, PUMPS FOR KIDS, INFANTS, AND NEONATES (PUMPKIN) CLINICAL TRIAL - DATA & CLINICAL COORDINATING CENTER
$1,420,558Sandi Siami · New England Research Institutes, Inc. · N01 · FY2017 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$1,419,180Joseph Eric Levitt · Stanford University · UG3 · FY2019 · HL
Genetic Studies of Human Communications Disorders
$1,418,652Dennis Drayna · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC
Magscrew TAH Testing thru Pre-Clinical Readiness
$1,417,976Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · HL
Data Science Research
$1,417,928Santosh Kumar · University Of Memphis · U54 · FY2015 · EB